vs
ExlService Holdings, Inc.（EXLS）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
ExlService Holdings, Inc.的季度营收约是Sotera Health Co的1.8倍（$542.6M vs $303.4M），Sotera Health Co净利率更高（11.5% vs 11.1%，领先0.4%），ExlService Holdings, Inc.同比增速更快（12.7% vs 4.6%），ExlService Holdings, Inc.自由现金流更多（$106.5M vs $52.4M），过去两年ExlService Holdings, Inc.的营收复合增速更高（11.5% vs 10.6%）
ExlService Holdings Inc.是全球知名的分析与数字解决方案服务商，服务覆盖保险、医疗健康、银行金融服务、媒体、零售等多个行业，总部位于纽约，在美国、欧洲、亚洲、拉美、澳大利亚、南非等地拥有超过5.4万名专业从业人员。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
EXLS vs SHC — 直观对比
营收规模更大
EXLS
是对方的1.8倍
$303.4M
营收增速更快
EXLS
高出8.1%
4.6%
净利率更高
SHC
高出0.4%
11.1%
自由现金流更多
EXLS
多$54.1M
$52.4M
两年增速更快
EXLS
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $542.6M | $303.4M |
| 净利润 | $60.2M | $34.8M |
| 毛利率 | 38.6% | 54.7% |
| 营业利润率 | 14.4% | 23.2% |
| 净利率 | 11.1% | 11.5% |
| 营收同比 | 12.7% | 4.6% |
| 净利润同比 | 18.9% | 182.8% |
| 每股收益（稀释后） | $0.38 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXLSSHC
| Q4 25 | $542.6M | $303.4M | ||
| Q3 25 | $529.6M | $311.3M | ||
| Q2 25 | $514.5M | $294.3M | ||
| Q1 25 | $501.0M | $254.5M | ||
| Q4 24 | $481.4M | $290.2M | ||
| Q3 24 | $472.1M | $285.5M | ||
| Q2 24 | $448.4M | $276.6M | ||
| Q1 24 | $436.5M | $248.2M |
净利润EXLSSHC
| Q4 25 | $60.2M | $34.8M | ||
| Q3 25 | $58.2M | $48.4M | ||
| Q2 25 | $66.1M | $8.0M | ||
| Q1 25 | $66.6M | $-13.3M | ||
| Q4 24 | $50.7M | $12.3M | ||
| Q3 24 | $53.0M | $17.0M | ||
| Q2 24 | $45.8M | $8.8M | ||
| Q1 24 | $48.8M | $6.3M |
毛利率EXLSSHC
| Q4 25 | 38.6% | 54.7% | ||
| Q3 25 | 38.5% | 57.0% | ||
| Q2 25 | 37.7% | 56.6% | ||
| Q1 25 | 38.6% | 53.2% | ||
| Q4 24 | 38.1% | 56.6% | ||
| Q3 24 | 37.8% | 55.4% | ||
| Q2 24 | 37.1% | 55.2% | ||
| Q1 24 | 37.4% | 51.2% |
营业利润率EXLSSHC
| Q4 25 | 14.4% | 23.2% | ||
| Q3 25 | 14.4% | 23.4% | ||
| Q2 25 | 15.8% | 6.4% | ||
| Q1 25 | 15.7% | -5.8% | ||
| Q4 24 | 14.8% | 30.0% | ||
| Q3 24 | 14.7% | 28.2% | ||
| Q2 24 | 13.7% | 27.8% | ||
| Q1 24 | 14.1% | 21.4% |
净利率EXLSSHC
| Q4 25 | 11.1% | 11.5% | ||
| Q3 25 | 11.0% | 15.5% | ||
| Q2 25 | 12.8% | 2.7% | ||
| Q1 25 | 13.3% | -5.2% | ||
| Q4 24 | 10.5% | 4.2% | ||
| Q3 24 | 11.2% | 6.0% | ||
| Q2 24 | 10.2% | 3.2% | ||
| Q1 24 | 11.2% | 2.5% |
每股收益（稀释后）EXLSSHC
| Q4 25 | $0.38 | $0.12 | ||
| Q3 25 | $0.36 | $0.17 | ||
| Q2 25 | $0.40 | $0.03 | ||
| Q1 25 | $0.40 | $-0.05 | ||
| Q4 24 | $0.31 | $0.05 | ||
| Q3 24 | $0.33 | $0.06 | ||
| Q2 24 | $0.28 | $0.03 | ||
| Q1 24 | $0.29 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $328.4M | $344.6M |
| 总债务越低越好 | $298.6M | $2.1B |
| 股东权益账面价值 | $912.7M | $606.0M |
| 总资产 | $1.7B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.33× | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资EXLSSHC
| Q4 25 | $328.4M | $344.6M | ||
| Q3 25 | $390.1M | $299.2M | ||
| Q2 25 | $353.3M | $332.4M | ||
| Q1 25 | $331.4M | $304.4M | ||
| Q4 24 | $340.6M | $277.2M | ||
| Q3 24 | $325.8M | $306.7M | ||
| Q2 24 | $276.1M | $246.1M | ||
| Q1 24 | $246.2M | $261.1M |
总债务EXLSSHC
| Q4 25 | $298.6M | $2.1B | ||
| Q3 25 | $354.8M | $2.1B | ||
| Q2 25 | $260.0M | $2.2B | ||
| Q1 25 | $307.3M | $2.2B | ||
| Q4 24 | $288.5M | $2.2B | ||
| Q3 24 | $344.7M | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
股东权益EXLSSHC
| Q4 25 | $912.7M | $606.0M | ||
| Q3 25 | $952.4M | $550.5M | ||
| Q2 25 | $1.1B | $511.3M | ||
| Q1 25 | $1.0B | $414.1M | ||
| Q4 24 | $929.9M | $404.9M | ||
| Q3 24 | $907.6M | $470.2M | ||
| Q2 24 | $852.6M | $422.8M | ||
| Q1 24 | $803.3M | $429.4M |
总资产EXLSSHC
| Q4 25 | $1.7B | $3.3B | ||
| Q3 25 | $1.7B | $3.2B | ||
| Q2 25 | $1.7B | $3.2B | ||
| Q1 25 | $1.7B | $3.1B | ||
| Q4 24 | $1.6B | $3.1B | ||
| Q3 24 | $1.6B | $3.1B | ||
| Q2 24 | $1.5B | $3.1B | ||
| Q1 24 | $1.4B | $3.1B |
负债/权益比EXLSSHC
| Q4 25 | 0.33× | 3.53× | ||
| Q3 25 | 0.37× | 3.89× | ||
| Q2 25 | 0.25× | 4.34× | ||
| Q1 25 | 0.30× | 5.36× | ||
| Q4 24 | 0.31× | 5.49× | ||
| Q3 24 | 0.38× | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $117.4M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | $106.5M | $52.4M |
| 自由现金流率自由现金流/营收 | 19.6% | 17.3% |
| 资本支出强度资本支出/营收 | 2.0% | 16.7% |
| 现金转化率经营现金流/净利润 | 1.95× | 2.96× |
| 过去12个月自由现金流最近4个季度 | $298.1M | $149.2M |
8季度趋势，按日历期对齐
经营现金流EXLSSHC
| Q4 25 | $117.4M | $103.1M | ||
| Q3 25 | $120.7M | $71.2M | ||
| Q2 25 | $109.4M | $57.4M | ||
| Q1 25 | $3.2M | $55.5M | ||
| Q4 24 | $105.3M | $55.7M | ||
| Q3 24 | $110.1M | $97.5M | ||
| Q2 24 | $74.9M | $61.3M | ||
| Q1 24 | $-21.9M | $9.7M |
自由现金流EXLSSHC
| Q4 25 | $106.5M | $52.4M | ||
| Q3 25 | $106.4M | $35.0M | ||
| Q2 25 | $95.0M | $26.2M | ||
| Q1 25 | $-9.7M | $35.6M | ||
| Q4 24 | $95.3M | $-10.2M | ||
| Q3 24 | $97.3M | $61.1M | ||
| Q2 24 | $62.8M | $19.4M | ||
| Q1 24 | $-33.1M | $-25.2M |
自由现金流率EXLSSHC
| Q4 25 | 19.6% | 17.3% | ||
| Q3 25 | 20.1% | 11.2% | ||
| Q2 25 | 18.5% | 8.9% | ||
| Q1 25 | -1.9% | 14.0% | ||
| Q4 24 | 19.8% | -3.5% | ||
| Q3 24 | 20.6% | 21.4% | ||
| Q2 24 | 14.0% | 7.0% | ||
| Q1 24 | -7.6% | -10.2% |
资本支出强度EXLSSHC
| Q4 25 | 2.0% | 16.7% | ||
| Q3 25 | 2.7% | 11.6% | ||
| Q2 25 | 2.8% | 10.6% | ||
| Q1 25 | 2.6% | 7.8% | ||
| Q4 24 | 2.1% | 22.7% | ||
| Q3 24 | 2.7% | 12.7% | ||
| Q2 24 | 2.7% | 15.2% | ||
| Q1 24 | 2.6% | 14.1% |
现金转化率EXLSSHC
| Q4 25 | 1.95× | 2.96× | ||
| Q3 25 | 2.08× | 1.47× | ||
| Q2 25 | 1.66× | 7.21× | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 2.08× | 4.52× | ||
| Q3 24 | 2.08× | 5.73× | ||
| Q2 24 | 1.63× | 7.00× | ||
| Q1 24 | -0.45× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
